Literature DB >> 9153663

Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons.

B Knusel1, H Gao, T Okazaki, T Yoshida, N Mori, F Hefti, D R Kaplan.   

Abstract

Chronic exposure of brain neurons to nerve growth factor in vitro and in vivo results in increased levels of the nerve growth factor receptor TrkA. In contrast, in the present study, we have found that chronic exposure of rat embryonic cortical neurons to brain-derived neurotrophic factor (BDNF) leads to a pronounced reduction of the levels of protein and messenger RNA for the full-length but not the truncated BDNF receptor TrkB. Similar effects were observed with the other TrkB ligands neurotrophin-3 and neurotrophin-4/5. After pretreatment with BDNF, neurotrophin-3 or neurotrophin-4/5, subsequent tyrosine phosphorylation responses of the remaining Trks to the same factors were greatly reduced. Three days exposure of rat embryonic cortical neurons to BDNF induced an absolute refractory period of several hours, with no subsequent response to the same factor. Similar but less pronounced refractory effects were observed with neurotrophin-3 and neurotrophin-4/5. Our results suggest a negative regulatory effect of BDNF and other TrkB ligands on TrkB receptors. Down-regulation of the TrkB response by its ligands might play a role in the control of BDNF action during early development, when BDNF levels significantly increase. Our findings are also of potential clinical relevance, since the possibility of ligand-induced down-regulation of the receptor response needs to be addressed when considering BDNF or other neurotrophins for the therapy of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153663     DOI: 10.1016/s0306-4522(96)00616-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Regulation of trafficking of activated TrkA is critical for NGF-mediated functions.

Authors:  Tao Yu; Laura Calvo; Begoña Anta; Saray López-Benito; Eileen Southon; Moses V Chao; Lino Tessarollo; Juan C Arévalo
Journal:  Traffic       Date:  2011-02-01       Impact factor: 6.215

Review 2.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

3.  A novel endocytic recycling signal distinguishes biological responses of Trk neurotrophin receptors.

Authors:  Zhe-Yu Chen; Alessandro Ieraci; Michael Tanowitz; Francis S Lee
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

4.  Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury.

Authors:  Arthur J Weber; Suresh Viswanáthan; Chidambaram Ramanathan; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-26       Impact factor: 4.799

5.  BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.

Authors:  Itaru Miura; Jian-Ping Zhang; Masahiro Nitta; Todd Lencz; John M Kane; Anil K Malhotra; Hirooki Yabe; Christoph U Correll
Journal:  Schizophr Res       Date:  2014-01-07       Impact factor: 4.939

6.  Cerebellar brain-derived neurotrophic factor-TrkB defect associated with impairment of eyeblink conditioning in Stargazer mutant mice.

Authors:  X Qiao; L Chen; H Gao; S Bao; F Hefti; R F Thompson; B Knusel
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

7.  Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression.

Authors:  J C Lauterborn; E Pineda; L Y Chen; E A Ramirez; G Lynch; C M Gall
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

Review 8.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

9.  Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.

Authors:  R Chavez-Valdez; L J Martin; S Razdan; E B Gauda; F J Northington
Journal:  Neuroscience       Date:  2013-12-17       Impact factor: 3.590

10.  Antidepressant-like activity of zinc: further behavioral and molecular evidence.

Authors:  Magdalena Sowa-Kućma; Beata Legutko; Bernadeta Szewczyk; Kinga Novak; Paweł Znojek; Ewa Poleszak; Mariusz Papp; Andrzej Pilc; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2008-09-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.